Page last updated: 2024-10-26

brl 42810 and Immunologic Deficiency Syndromes

brl 42810 has been researched along with Immunologic Deficiency Syndromes in 1 studies

Immunologic Deficiency Syndromes: Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nosari, A1
Montillo, M1
Morra, E1

Other Studies

1 other study available for brl 42810 and Immunologic Deficiency Syndromes

ArticleYear
Infectious toxicity using alemtuzumab.
    Haematologica, 2004, Volume: 89, Issue:12

    Topics: 2-Aminopurine; Alemtuzumab; Antibiotic Prophylaxis; Antibodies, Monoclonal; Antibodies, Monoclonal,

2004